Mainz Biomed (MYNZ) Short Interest Ratio & Short Volume → Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad) Free MYNZ Stock Alerts $0.90 0.00 (0.00%) (As of 04/19/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Mainz Biomed Short Interest DataCurrent Short Volume307,300 sharesPrevious Short Volume317,100 sharesChange Vs. Previous Month-3.09%Dollar Volume Sold Short$316,519.00Short Interest Ratio / Days to Cover3.5Last Record DateMarch 31, 2024Float Size13,120,000 sharesShort Percent of Float2.34%Today's Trading Volume62,539 sharesAverage Trading Volume82,691 sharesToday's Volume Vs. Average76% Short Selling Mainz Biomed ? Sign up to receive the latest short interest report for Mainz Biomed and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMYNZ Short Interest Over TimeMYNZ Days to Cover Over TimeMYNZ Percentage of Float Shorted Over Time Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> Mainz Biomed Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2024307,300 shares $316,519.00 -3.1%2.3%3.5 $1.03 3/15/2024317,100 shares $329,784.00 -8.7%2.8%3.5 $1.04 2/29/2024347,200 shares $306,959.52 -17.6%3.0%2.8 $0.88 2/15/2024421,500 shares $421,500.00 -16.1%3.7%2.1 $1.00 1/31/2024502,100 shares $487,037.00 -14.9%4.4%2 $0.97 1/15/2024589,900 shares $704,930.50 +8.0%5.2%2.5 $1.20 Get the Latest News and Ratings for MYNZ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mainz Biomed and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023546,100 shares $633,476.00 +68.6%4.8%2.4 $1.16 12/15/2023324,000 shares $336,960.00 +112.6%2.8%1.4 $1.04 11/30/2023152,400 shares $173,736.00 +10.0%1.3%0.5 $1.14 11/15/2023138,600 shares $167,706.00 +78.2%1.2%0.7 $1.21 10/31/202377,800 shares $156,378.00 -29.2%0.7%0.6 $2.01 10/15/2023109,900 shares $254,968.00 -12.1%1.0%0.9 $2.32 9/30/2023125,000 shares $365,000.00 -57.7%1.1%1 $2.92 9/15/2023295,700 shares $1.05 million +682.3%2.7%2.6 $3.54 8/31/202337,800 shares $115,668.00 +65.8%0.3%1.2 $3.06 8/15/202322,800 shares $71,820.00 +168.2%0.2%0.9 $3.15 7/31/20238,500 shares $36,210.00 -52.3%0.1%0.4 $4.26 7/15/202317,800 shares $87,220.00 +11.3%0.2%0.6 $4.90 6/30/202316,000 shares $76,480.00 -35.5%0.1%0.5 $4.78 6/15/202324,800 shares $121,520.00 -12.4%0.2%0.6 $4.90 5/31/202328,300 shares $155,367.00 -28.4%0.3%0.6 $5.49 5/15/202339,500 shares $216,855.00 +208.6%0.4%0.8 $5.49 4/30/202312,800 shares $50,816.00 -67.0%0.1%0.3 $3.97 4/15/202338,800 shares $230,472.00 -23.2%0.4%0.9 $5.94 3/31/202350,500 shares $317,140.00 +155.1%0.7%1.3 $6.28 3/15/202319,800 shares $124,344.00 -18.5%0.3%0.7 $6.28 2/28/202324,300 shares $172,287.00 +88.4%0.3%0.9 $7.09 2/15/202312,900 shares $88,365.00 +76.7%0.2%0.6 $6.85 1/31/20237,300 shares $48,180.00 -21.5%N/A0.5 $6.60 1/15/20239,300 shares $61,566.00 +304.4%N/A0.6 $6.62 12/30/20222,300 shares $16,330.00 -60.3%N/A0.1 $7.10 12/15/20225,800 shares $44,254.00 -71.1%N/A0.3 $7.63 11/30/202220,100 shares $176,277.00 +27.2%N/A1 $8.77 11/15/202215,800 shares $123,398.00 -6.0%N/A0.8 $7.81 10/31/202216,800 shares $119,280.00 -2.9%N/A0.7 $7.10 10/15/202217,300 shares $121,273.00 +1.8%N/A0.7 $7.01 9/30/202217,000 shares $117,130.00 -30.9%N/A0.6 $6.89 9/15/202224,600 shares $214,543.98 -32.2%N/A0.9 $8.72 8/31/202236,300 shares $318,714.00 -17.1%N/A1.2 $8.78 8/15/202243,800 shares $404,712.00 +13.5%N/A1.6 $9.24SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. MYNZ Short Interest - Frequently Asked Questions What is Mainz Biomed's current short interest? Short interest is the volume of Mainz Biomed shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 307,300 shares of MYNZ short. 2.34% of Mainz Biomed's shares are currently sold short. Learn More on Mainz Biomed's current short interest. What is a good short interest ratio for Mainz Biomed? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MYNZ shares currently have a short interest ratio of 4.0. Learn More on Mainz Biomed's short interest ratio. What is a good short interest percentage for Mainz Biomed? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.34% of Mainz Biomed's floating shares are currently sold short. Is Mainz Biomed's short interest increasing or decreasing? Mainz Biomed saw a decrease in short interest in March. As of March 31st, there was short interest totaling 307,300 shares, a decrease of 3.1% from the previous total of 317,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Mainz Biomed's float size? Mainz Biomed currently has issued a total of 0 shares. Some of Mainz Biomed's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Mainz Biomed currently has a public float of 13,120,000 shares. How does Mainz Biomed's short interest compare to its competitors? 2.34% of Mainz Biomed's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Mainz Biomed: Context Therapeutics Inc. (0.08%), Grifols, S.A. (2.32%), LAVA Therapeutics (1.50%), NLS Pharmaceutics Ltd. (1.54%), Pharvaris (0.10%), Procaps Group S.A. (0.03%), Qilian International Holding Group Limited (0.07%), American Oncology Network, Inc. (1.02%), Concord Medical Services Holdings Limited (0.06%), Lucid Diagnostics Inc. (3.81%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Mainz Biomed stock? Short selling MYNZ is an investing strategy that aims to generate trading profit from Mainz Biomed as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Mainz Biomed? A short squeeze for Mainz Biomed occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MYNZ, which in turn drives the price of the stock up even further. How often is Mainz Biomed's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MYNZ, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: CNTX Short Squeeze GRFS Short Squeeze LVTX Short Squeeze NLSP Short Squeeze PHVS Short Squeeze PROC Short Squeeze QLI Short Squeeze TLSA Short Squeeze ATNFW Short Squeeze ACONW Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MYNZ) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving TrendsUrgent alert: open this for a huge profit potentialTimothy Sykes